alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
## I N T H E C O U R T O F C R I M I N A L A P P E A L S O F T E X A S NO. WR-90,928-01

EX P ARTE MEGA N MAR IE ALEGRIA, Applicant

ON AP P LICATION FOR A WRIT OF HABEAS CORP US CAUSE NO. 1327659-A IN THE 184TH DIS TRICT COURT

F ROM HARRIS COUNTY

Per curiam . K

E A S L E R and Y E A R Y , JJ., concurring.

O P I N I O N Applicant was convicted of possession of a controlled substance and sentenc ed to two y ear s’ imprisonment. Applicant filed this application for a writ of habea s corpus in the county of conviction, and the district cler k forwa rded it to this Court. See T E X . C O D E C R I M . P R O C . art. 11.07. Applicant conte nds, among other thing s, that her due proce ss rig hts wer e viol ated because afte r she pleade d g uilty , the evidenc e in her case was analy zed and found not to contain a controlled substance o r d ang erous drug

. The trial court made finding s of fac t and conclusions of law and

rec ommended that we set aside Applica nt’s conviction. Relief is g rante d. Ex parte Mable , 443 S.W .3d 129 (Tex. Crim. App. 2014). The judgme nt in cause number 1327659 in the 184t h District C o urt of Harris C ounty is set aside, and Applicant2

is rema nded t o t h e custody of the Sheriff of Har ris County to answe r the char g es as set out in the information. The trial c ourt shall issue any nece ssary bench war rant within ten day s from the date of this Court’s mandate. Co p ie s o f th is opinion shall be sent to the Texas Depa rtment of Criminal J ustice–C o r r e c ti o n a l I nstitut ions Division and the Boa rd of Par dons and Paroles.

Deliver ed: Marc h 11, 2020 Do not publish
| (logo) WELLS FARGO | CMBS Department

 MAC N9401-011

1055 10th Avenue SE

Minneapolis, MN 55414 |
|--------------------|-----------------------------------------------------------------------------|

 

Morgan Stanley Capital I Inc.

1585 Broadway

New York, New York 10036

 

 

RE: Annual Statement of Compliance for Morgan Stanley Bank Of America Merrill Lynch Trust 2013-C8, Commercial Mortgage Pass-Through Certificates Series 2013-C8

 

Per the Pooling and Servicing Agreement dated as of February 1, 2013 (the "Agreement"), the undersigned, a duly authorized officer of Wells Fargo Bank, N.A., as Custodian ("Wells Fargo"), hereby certifies as follows as of and for the year ending December 31, 2015 (the "Reporting Period"):

 

(a) A review of Wells Fargo's activities during the Reporting Period and of its performance under the Agreement has been made under such officer's supervision; and

 

(b) To the best of such officer's knowledge, based on such review, Wells Fargo has fulfilled all of its obligations under the Agreement in all material respects throughout the Reporting Period.

 

 

March 1, 2016

/s/ Gail Vannest

GAIL VANNEST

Vice President

 

 

Wells Fargo Bank, N.A.
OFFICE OF 

Jimmy Harris 

Madison County Mayor 

Mr. Scott Faulk 

Essential Air Service Division 

Department of Transportation 

1200 New Jersey Avenue, SE 

Washington, D.C. 20590 

Dear Mr. Faulk: 

December 23, 2014 

100 East Main, Suite 302 

Jackson, Tennessee 38301 

Phone: 731-423-6020 

Fax: 731-988-3820 

As you are aware, our past EAS carriers have not been able to increase our 

passenger count to an acceptable level for our airport. There have been various 

issues with these carriers leading to this problem but, I believe, the overriding 

factors with these carriers have been the routes (Memphis & Nashville), their dismal 

customer service and their lack of promotion in our community. We now have a 

carrier bidding on this service, Air Choice One, who brings a successful track record 

of service to other EAS communities and a proposed route to St. Louis. I think Air 

Choice One will bring better service to our community. Af~er meetings and 

discussions with many business and industrial leaders in Jackson with Air Choice 

One, we are convinced they can build a successful airline service for our community. 

The Jackson-Madison County Airport Authority has indorsed the selection of Air 

Choice One to provide service for Jackson, Madison County, Tennessee. I join in 

their decision and hope you will consider our community's endorsement in making 

your decision. 

Should you wish to discuss this issue, please give me a call. ' .. ; . . ~· ' '• - . . ... 

,·.:: 

.·:_:;; :: .. 

·.- '•.- .. ·-.·· . I . • ' 

_ ..~ . . . i . ' .. 

• ......... 1:: ... .. 

.· .: :·:.=!-_;; : '. .: f
Registered Owner Name:

Crossview Concepts Corporation, Inc.

Registered Owner Address:

1986 James Gaynor Street

Fallbrook, CA 92028

Attn: Kevin R. Adkins

Aircraft Description:

Hexcopter

Aircraft Serial Number:

NA

Aircraft Builder:

YUNEEC

Year Manufactured:

NA

Aircraft Model Designation:

TORNADO H920

Engine Model:

Registered Owner Name:

Crossview Concepts Corporation, Inc.

Registered Owner Address:

1986 James Gaynor Street

Fallbrook, CA 92028

Attn: Kevin R. Adkins

Aircraft Description:

Quadcopter

Aircraft Serial Number:

NA

Aircraft Builder:

YUNEES

Year Manufactured:

NA

Aircraft Model Designation:

TYPHOON Q500 Series (4K, +, Pro3)

Engine Model:

Registered Owner Name:

Crossview Concepts Corporation, Inc.

Registered Owner Address:

1986 James Gaynor Street

Fallbrook, CA 92028

Attn: Kevin R. Adkins

Aircraft Description:

Fixed-wing

Aircraft Serial Number:

NA

Aircraft Builder:

SWIFT RADIOPLANES

Year Manufactured:

NA

Aircraft Model Designation:

LYNX M UAS

Engine Model:

None of our operations would change; we are requesting to add additional Unmanned Aircraft to our exemption for greater 

flexibility. Crossview Concepts Corporation, Inc. (CCC, Inc.) is requesting to amend that exemption to include five additional 

Unmanned Aircraft models: TORNADO H920, TYPHOON Q500 4K, TYPHOON Q500+, TYPHOON q500 Pro3 LYNX M UAS. All 

Unmanned Aircraft are less than 55 lbs including payload(s). The following Exemptions have been previously approved or is 

currently under review by the FAA for the associated SUAS. Listed aircraft under review have had operating manuals and checklist 

supported by identified petitioners.

SUAS Exemption No. Regulatory Docket No.or Remarks___________________________________

Lynx M UAS Under Review Swift Radioplanes, LLC posted §333 Exemption request 13 Aug 15

Typhoon Q500 Series 11787 FAA-2-15-0997

Tornado H920 Under Review D’Avion, LLC posted §333 Exemption request 2 Sep 15

(14 CFR § 11.81(h)) Request authorized sUAS operations for this exemption to support the aerial data/photography of a civilian 

offshore oil rig located in Venezuela in support of civilian logistics company based in Humble, Texas (International Frontier 

Forwarders). Purpose is to create a 3D map and 3D model of the offshore oil rig.

Respectfully,

Kevin R. Adkins

President / CEO

Crossview Concepts Corporation, Inc.

§333 Exemption Amendment for

Crossview Concepts Corporation, Inc.

Exemption No. 12073

Regulatory Docket No. FAA-2015-1367

13 Nov 15
4750

4950

4950

4800

4750

5000

4750

4850

4500

5400

5000

4800

4650

4850

4850

5250

4750

4800

4900

4550

5000

4900

4850

5000

4900

5300

5000

4950

4600

5150

4950

4800

5100

4950

4800

5050

5000

4950 4900

5050 5000

4900

4650

4900

4850

4950

4650

4750

4500

5350

4800

4800

4550

4700

4650

5150

4750

4900

4900

5000

4900

4550

5050

4900

4950

5350

4950

4900

4800

4450

4550

4900

5250

4700

4850

4650

5000

4950

4950

4850

4750

4800

4600

5250

5150

4750

4750

4850

5150

4950

4900

4750

4850

4600

4700

5100

4950

4400

4750

4850

4700

4700

4650

4950

5150

5150

4700

5150

10

10

E A G L E F L A T R D

E A G L E

F L AT R D

10

10

E A G L E F L A T R D

E A G L E

F L AT R D

Railroad Tank

Lena

Tank

Williams Tank

South Pond

Williams

Tank

Davis Tank

Jenkins

Tank

South

Davis Tank

England Pond

Camel Draw

Dome

Peak

Streeruwitz Hills

Sierra

Diablo

Wilkin

Ranch

Dome

Peak

Sierra

Blanca

Bean

Hills

Allamoore Devil

Ridge

Pierce

Ranch

Sneed

Mountain

Movie

Mountain

Grayton

Lake

34

4

12'

000

86

N

34

34

30"

54

FEET

86

34

55

34

4 4

46

10' E

30" 81 4

4

10'

000m

53

30"

44

07'

79

000

34

15' 82

49

12'

10

34

4 000

4

56

34

47

52

30"

81

57

4

31°

12'

34

83

85

34

34

4

34

51

15'

34

87

55

10'

34

000m 31° 4

47

45

82

34

000m

52

10

34

105°

34

105°

105°

50

34

FEET

760 000 FEET

105°

12'

30"

10'

07'

07'

31°15'

30"

450

790 FEET

30"

15' 30"

07'

31°

410

E

34

4

34

4

34

4

4

000m

34

34

34

34

34

4

4 4

48

53

87

54

45

44

78

56

77

78

N

85

46

49

79

50

51

83

U.S. DEPARTMENT OF THE INTERIOR

U. S. GEOLOGICAL SURVEY

TEXAS

ADJOINING 7.5' QUADRANGLES

QUADRANGLE LOCATION

TX 31105-113

DOME PEAK, TX

2010

Interstate Route State Route

ROAD CLASSIFICATION

Interstate Route US Route State Route

Ramp 4WD

US Route Local Road

DOME PEAK QUADRANGLE

TEXAS

7.5-MINUTE SERIES

Zone 13R

Imagery.............................................NAIP, September 2008

Roads.....................................US Census Bureau TIGER data

with limited USGS updates, 2008

Names...............................................................GNIS, 2008

Hydrography.................National Hydrography Dataset, 1995

Contours............................National Elevation Dataset, 2005

North American Datum of 1983 (NAD83)

World Geodetic System of 1984 (WGS84). Projection and

1 000-meter grid: Universal Transverse Mercator,

Produced by the United States Geological Survey

10 000-foot ticks: Texas Coordinate System of 1983

(central zone)

1000 500 0 METERS 1000 2000

1000 0 1000 2000 3000 4000 5000 6000 7000 8000 9000 10000

FEET

This map was produced to conform with version 0.5.10 of the

draft USGS Standards for 7.5-Minute Quadrangle Maps.

A metadata file associated with this product is also draft version 0.5.10

SCALE 1:24 000

1 0.5 0 1

MILES

MN

1 0.5 0 KILOMETERS 1 2

GN

UTM GRID AND 2010 MAGNETIC NORTH DECLINATION AT CENTER OF SHEET

0° 6 ́

2 MILS

8° 23 ́

149 MILS

U.S. National Grid

100,000-m Square ID

Grid Zone Designation

13R

DQ

CONTOUR INTERVAL 10 FEET
Exhibit 32.1

# Written Statement of
the Chief Executive Officer and Chief Financial OfficerPursuant to 18 U.S.C.
§1350

Solely
for the purposes of complying with 18 U.S.C. §1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, we hereby certify, based on our knowledge, that the
Report on Form 10-Q of the Company for the quarter ended June 30, 2009 (the
Report) fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 and that information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of
the Company.

/s/ Kerry L. Woody  
Kerry L. Woody
President and Chief
Executive Officer

/s/ Wayne E. Larsen  Wayne E. Larsen
Vice President Law/Finance & Secretary

July 31, 2009
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          MAR-31-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                             838
<INT-BEARING-DEPOSITS>                           4,157
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     57,104
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                         69,816
<ALLOWANCE>                                        311
<TOTAL-ASSETS>                                 137,056
<DEPOSITS>                                      83,327
<SHORT-TERM>                                    15,000
<LIABILITIES-OTHER>                              1,169
<LONG-TERM>                                     25,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            11
<OTHER-SE>                                      12,549
<TOTAL-LIABILITIES-AND-EQUITY>                 137,056
<INTEREST-LOAN>                                  5,394
<INTEREST-INVEST>                                3,254
<INTEREST-OTHER>                                   365
<INTEREST-TOTAL>                                 9,013
<INTEREST-DEPOSIT>                               3,878
<INTEREST-EXPENSE>                               5,920
<INTEREST-INCOME-NET>                            3,093
<LOAN-LOSSES>                                       66
<SECURITIES-GAINS>                                 479
<EXPENSE-OTHER>                                  2,545
<INCOME-PRETAX>                                  1,674
<INCOME-PRE-EXTRAORDINARY>                       1,674
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,073
<EPS-BASIC>                                     1.48
<EPS-DILUTED>                                     1.42
<YIELD-ACTUAL>                                    6.92
<LOANS-NON>                                        230
<LOANS-PAST>                                        47
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                    336
<ALLOWANCE-OPEN>                                   248
<CHARGE-OFFS>                                        2
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                  311
<ALLOWANCE-DOMESTIC>                               239
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                             72


</TABLE>
§ 801.1 Medical devices; name and place of business of manufacturer, packer or distributor. ( a ) The label of a device in package form shall specify conspicuously the name and place of business of the manufacturer, packer, or distributor.
( b ) The requirement for declaration of the name of the manufacturer, packer, or distributor shall be deemed to be satisfied, in the case of a corporation, only by the actual corporate name which may be preceded or followed by the name of the particular division of the corporation. Abbreviations for “Company,” “Incorporated,” etc., may be used and “The” may be omitted. In the case of an individual, partnership, or association, the name under which the business is conducted shall be used.
( c ) Where a device is not manufactured by the person whose name appears on the label, the name shall be qualified by a phrase that reveals the connection such person has with such device; such as, “Manufactured for ___”, “Distributed by _____”, or any other wording that expresses the facts.
( d ) The statement of the place of business shall include the street address, city, State, and Zip Code; however, the street address may be omitted if it is shown in a current city directory or telephone directory. The requirement for inclusion of the ZIP Code shall apply only to consumer commodity labels developed or revised after the effective date of this section. In the case of nonconsumer packages, the ZIP Code shall appear on either the label or the labeling (including the invoice).
( e ) If a person manufactures, packs, or distributes a device at a place other than his principal place of business, the label may state the principal place of business in lieu of the actual place where such device was manufactured or packed or is to be distributed, unless such statement would be misleading.
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1113 Bilirubin (total and unbound) in the neonate test system. ( a ) *Identification.* A bilirubin (total and unbound) in the neonate test system is a device intended to measure the levels of bilirubin (total and unbound) in the blood (serum) of newborn infants to aid in indicating the risk of bilirubin encephalopathy (kernicterus).
( b ) *Classification.* Class I.
[54 FR 30206, July 19, 1989]
4500

5000 5050

4850

4550

4400

4800

4800

4750

4850

4850

4750

4900

4600

4950

4750

4650

4800

4350

4900

4700

4850

4800

4600

4600

4300

4450

4900

4750

4700

4500

4650

4550

4950

4850

5000

4550

4550

4850

5100

4750

4450

4400

4900

10

10

10

10

G U E S T R A N C H R D

S O U T H E R N PA C IF IC R D

G U E S T R A N C H R D

S O U T H E R N PA C IF IC R D

G R E E N G A P R D

R IN C O N C A N Y O N R D

G R E E N G A P R D

10

10

10

10

G U E S T R A N C H R D

S O U T H E R N PA C IF IC R D

G U E S T R A N C H R D

S O U T H E R N PA C IF IC R D

G R E E N G A P R D

R IN C O N C A N Y O N R D

G R E E N G A P R D

Horse Trap Tank

Jim Bean

Tank

Camel Tank

Stage

Road Tank

Williams Tank

Silva

Tank

Martin Tank

Road Tank

Seventeen

Draw

Millican

Hills

Seventeen

Draw

Eagle Flat

Draw

Camel Draw

Carral

Arroyo

Allamoore

Dees

Ranch

Booth

Ranch

Espy

Ranch

Hot

Wells

Dome

Peak

Bass

Canyon

Bean

Hills

Hackett

Peak

Allamoore

Eagle

Mountains NW

Grayton

Lake

Sheep

Peak

Eagle

Mountains NE

105°00'

2' 2'30"

5'

30"

5'

07' 2'30"

31°07'

5'

30"

31°

07'

105°

31°

31°07'

105° 30"

00'

2'

30" 30"

5'

105°00' 4 000m 4 4

000m

34

34

34

4

34

4 4

4

34

000m

4

4

34

34

4 4

34

34

4 4

34

34

34

34

4

34

34

34

34

34

34

34

4

4

34

34

34

4

4

34

34

89 E 97 98 99

33

38

34

43

95

36

90

95

38

43

31

40

41

32

37

30

32

94

N

34

90

33

94

35 35

40

30

37

41

39

93 99

36

39

91 98

93

31

89

42

97

42

N

30"

00'

34

34

34

91

FEET

FEET

10 400 000

FEET

FEET

830 000

800 000

10 360 000

E 000m

U.S. DEPARTMENT OF THE INTERIOR

U. S. GEOLOGICAL SURVEY

TEXAS

ADJOINING 7.5' QUADRANGLES

QUADRANGLE LOCATION

TX 31105-111

ALLAMOORE, TX

2010

Interstate Route State Route

ROAD CLASSIFICATION

Interstate Route US Route State Route

Ramp 4WD

US Route Local Road

ALLAMOORE QUADRANGLE

TEXAS

7.5-MINUTE SERIES

Zone 13R

Imagery.............................................NAIP, September 2008

Roads.....................................US Census Bureau TIGER data

with limited USGS updates, 2008

Names...............................................................GNIS, 2008

Hydrography.................National Hydrography Dataset, 1995

Contours............................National Elevation Dataset, 2005

North American Datum of 1983 (NAD83)

World Geodetic System of 1984 (WGS84). Projection and

1 000-meter grid: Universal Transverse Mercator,

Produced by the United States Geological Survey

10 000-foot ticks: Texas Coordinate System of 1983

(central zone)

1000 500 0 METERS 1000 2000

1000 0 1000 2000 3000 4000 5000 6000 7000 8000 9000 10000

FEET

This map was produced to conform with version 0.5.10 of the

draft USGS Standards for 7.5-Minute Quadrangle Maps.

A metadata file associated with this product is also draft version 0.5.10

SCALE 1:24 000

1 0.5 0 1

MILES

MN

1 0.5 0 KILOMETERS 1 2

GN

UTM GRID AND 2010 MAGNETIC NORTH DECLINATION AT CENTER OF SHEET

0° 2 ́

1 MILS

8° 19 ́

148 MILS

U.S. National Grid

100,000-m Square ID

Grid Zone Designation

13R

DQ

CONTOUR INTERVAL 10 FEET
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1163 Cardiac allograft gene expression profiling test system. ( a ) *Identification.* A cardiac allograft gene expression profiling test system is a device that measures the ribonucleic acid (RNA) expression level of multiple genes and combines this information to yield a signature (pattern, classifier, index, score) to aid in the identification of a low probability of acute cellular rejection (ACR) in heart transplant recipients with stable allograft function.
( b ) *Classification.* Class II (special controls). The special control is FDA's guidance document entitled “Class II Special Controls Guidance Document: Cardiac Allograft Gene Expression Profiling Test Systems.” See § 862.1(d) for the availability of this guidance document.
[74 FR 53885, Oct. 21, 2009]
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.9 Limitations of exemptions from section 510(k) of the Federal Food, Drug, and Cosmetic Act (the act). The exemption from the requirement of premarket notification (section 510(k) of the act) for a generic type of class I or II device is only to the extent that the device has existing or reasonably foreseeable characteristics of commercially distributed devices within that generic type or, in the case of in vitro diagnostic devices, only to the extent that misdiagnosis as a result of using the device would not be associated with high morbidity or mortality. Accordingly, manufacturers of any commercially distributed class I or II device for which FDA has granted an exemption from the requirement of premarket notification must still submit a premarket notification to FDA before introducing or delivering for introduction into interstate commerce for commercial distribution the device when: ( a ) The device is intended for a use different from the intended use of a legally marketed device in that generic type of device; e.g., the device is intended for a different medical purpose, or the device is intended for lay use where the former intended use was by health care professionals only;
( b ) The modified device operates using a different fundamental scientific technology than a legally marketed device in that generic type of device; e.g., a surgical instrument cuts tissue with a laser beam rather than with a sharpened metal blade, or an in vitro diagnostic device detects or identifies infectious agents by using deoxyribonucleic acid (DNA) probe or nucleic acid hybridization technology rather than culture or immunoassay technology; or
( c ) The device is an in vitro device that is intended: ( 1 ) For use in the diagnosis, monitoring, or screening of neoplastic diseases with the exception of immunohistochemical devices;
( 2 ) For use in screening or diagnosis of familial or acquired genetic disorders, including inborn errors of metabolism;
( 3 ) For measuring an analyte that serves as a surrogate marker for screening, diagnosis, or monitoring life-threatening diseases such as acquired immune deficiency syndrome (AIDS), chronic or active hepatitis, tuberculosis, or myocardial infarction or to monitor therapy;
( 4 ) For assessing the risk of cardiovascular diseases;
( 5 ) For use in diabetes management;
( 6 ) For identifying or inferring the identity of a microorganism directly from clinical material;
( 7 ) For detection of antibodies to microorganisms other than immunoglobulin G (IgG) or IgG assays when the results are not qualitative, or are used to determine immunity, or the assay is intended for use in matrices other than serum or plasma;
( 8 ) For noninvasive testing as defined in § 812.3(k) of this chapter; and
( 9 ) For near patient testing (point of care).
[65 FR 2310, Jan. 14, 2000]
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.1240 Flow-directed catheter. ( a ) *Identification.* A flow-directed catheter is a device that incorporates a gas-filled balloon to help direct the catheter to the desired position.
( b ) *Classification.* Class II (performance standards).
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.5070 Bite block. ( a ) *Identification.* A bite block is a device inserted into a patient's mouth to protect the tongue and teeth while the patient is having convulsions.
( b ) *Classification.* Class II (performance standards).